Company intelligence / Profile preview

Nexol Biotech

Suwon, Gyeonggi-do, South Korea

Ownership: Private
Development stage: Other

Overview

Nexol Biotech is a South Korean biotechnology company specializing in the development of high-value bioactive materials derived from microalgae. The company focuses on the sustainable production of astaxanthin and other carotenoids using proprietary cultivation and extraction technologies. Their research aims to leverage the antioxidant and anti-inflammatory properties of these compounds for applications in functional foods, cosmetics, and potential therapeutic agents. Nexol Biotech is positioned as an innovator in the blue biotechnology sector, bridging the gap between marine resources and healthcare solutions.

Therapeutic areas: ImmunologyOtherMetabolic Disorders
Modalities: Small moleculeNatural product
Industry: Biotech

Beyond the preview

Go deeper on Nexol Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nexol Biotech.

Explore the full profile